Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Cush

Showing results (41-50 of 62) with videos related to

Pageof 7
Sort By:
Annals of the Rheumatic Diseases|October 5, 2013
Update on the safety profile of certolizumab pegol in rheumatoid arthritis: an integrated analysis from clinical trialsV P Bykerk, J Cush, K Winthrop, et al.
The Journal of Rheumatology|November 3, 2015
Pregnancy Outcomes in Subjects Exposed to Certolizumab PegolMegan E B Clowse, Douglas C Wolf, Frauke Förger, et al.
Arthritis and Rheumatism|April 13, 2004
The safety and efficacy of leflunomide in combination with infliximab in rheumatoid arthritisK E Hansen, J Cush, A Singhal, et al.
Arthritis Care & Research|July 12, 2012
Comprehensive tuberculosis screening program in patients with inflammatory arthritides treated with golimumab, a human anti-tumor necrosis factor antibody, in Phase III clinical trialsElizabeth C Hsia, John J Cush, Eric L Matteson, et al.
Arthritis and Rheumatism|January 1, 1995
Elevated interleukin-10 levels in patients with rheumatoid arthritisJ J Cush, J B Splawski, R Thomas, et al.
Seminars in Arthritis and Rheumatism|May 24, 2012
Proceedings of the 2012 Rheumatology Winter Clinical SymposiaArthur Kavanaugh, George Martin, John J Cush, et al.
The Journal of Rheumatology. Supplement|February 6, 2009
Unresolved issues in identifying and overcoming inadequate response in rheumatoid arthritis: weighing the evidenceStanley B Cohen, Marc D Cohen, John J Cush, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|April 7, 2018
Pregnancy Outcomes After Exposure to Certolizumab Pegol: Updated Results From a Pharmacovigilance Safety DatabaseMegan E B Clowse, Angela E Scheuerle, Christina Chambers, et al.
Seminars in Arthritis and Rheumatism|June 5, 2013
Proceedings of the 2013 Rheumatology Winter Clinical SymposiaArthur Kavanaugh, Roy Fleischmann, Martin Jan Bergman, et al.
The Journal of Rheumatology|June 2, 2004
The efficacy of switching from etanercept to infliximab in patients with rheumatoid arthritisKaren E Hansen, Julie P Hildebrand, Mark C Genovese, et al.
Pageof 7

Showing results (41-50 of 62) with videos related to

Sort By:
Pageof 7
Annals of the Rheumatic Diseases|October 5, 2013
Update on the safety profile of certolizumab pegol in rheumatoid arthritis: an integrated analysis from clinical trialsV P Bykerk, J Cush, K Winthrop, et al.
The Journal of Rheumatology|November 3, 2015
Pregnancy Outcomes in Subjects Exposed to Certolizumab PegolMegan E B Clowse, Douglas C Wolf, Frauke Förger, et al.
Arthritis and Rheumatism|April 13, 2004
The safety and efficacy of leflunomide in combination with infliximab in rheumatoid arthritisK E Hansen, J Cush, A Singhal, et al.
Arthritis Care & Research|July 12, 2012
Comprehensive tuberculosis screening program in patients with inflammatory arthritides treated with golimumab, a human anti-tumor necrosis factor antibody, in Phase III clinical trialsElizabeth C Hsia, John J Cush, Eric L Matteson, et al.
Arthritis and Rheumatism|January 1, 1995
Elevated interleukin-10 levels in patients with rheumatoid arthritisJ J Cush, J B Splawski, R Thomas, et al.
Seminars in Arthritis and Rheumatism|May 24, 2012
Proceedings of the 2012 Rheumatology Winter Clinical SymposiaArthur Kavanaugh, George Martin, John J Cush, et al.
The Journal of Rheumatology. Supplement|February 6, 2009
Unresolved issues in identifying and overcoming inadequate response in rheumatoid arthritis: weighing the evidenceStanley B Cohen, Marc D Cohen, John J Cush, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|April 7, 2018
Pregnancy Outcomes After Exposure to Certolizumab Pegol: Updated Results From a Pharmacovigilance Safety DatabaseMegan E B Clowse, Angela E Scheuerle, Christina Chambers, et al.
Seminars in Arthritis and Rheumatism|June 5, 2013
Proceedings of the 2013 Rheumatology Winter Clinical SymposiaArthur Kavanaugh, Roy Fleischmann, Martin Jan Bergman, et al.
The Journal of Rheumatology|June 2, 2004
The efficacy of switching from etanercept to infliximab in patients with rheumatoid arthritisKaren E Hansen, Julie P Hildebrand, Mark C Genovese, et al.
Pageof 7